General form of registration statement for all companies including face-amount certificate companies

Convertible Preferred Stock, Common Stock and Stockholders' Deficit

v3.21.2
Convertible Preferred Stock, Common Stock and Stockholders' Deficit
6 Months Ended 12 Months Ended
Jun. 30, 2021
Dec. 31, 2020
Stockholders' Equity Note [Abstract]    
Convertible Preferred Stock, Common Stock and Stockholders' Deficit
Note 8. Convertible Preferred Stock, Common Stock and Stockholders’ Deficit
The following table summarizes details of convertible preferred stock authorized, issued and outstanding as of June 30, 2021 and December 31, 2020:
 
 
  
June 30, 2021
 
(in thousands, except for share counts)
  
Shares
Authorized
 
  
Shares Issued
and
Outstanding
 
  
Issuance
Price
Per
Share
 
  
Net
Carrying
Value
 
  
Liquidation
Preference
 
Series Seed
     18,233,848        17,918,211      $ 0.0618      $ 1,107      $ 1,107  
Series A
     28,725,920        28,725,920        0.2959        8,437        8,500  
Series B
     34,391,480        34,391,480        0.4414        15,096        15,180  
Series C
     14,468,290        14,468,290        2.0735        29,881        30,000  
Series D
     17,599,646        17,579,656        4.7523        83,431        83,544  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total convertible preferred stock
     113,419,184        113,083,557              
$
137,952     
$
138,331  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
 
  
December 31, 2020
 
(in thousands, except for share counts)
  
Shares
Authorized
 
  
Shares Issued
and
Outstanding
 
  
Issuance
Price
Per
Share
 
  
Net
Carrying
Value
 
  
Liquidation
Preference
 
Series Seed
     18,233,848        17,918,211      $ 0.0618      $ 1,107      $ 1,107  
Series A
     28,725,920        28,725,920        0.2959        8,437        8,500  
Series B
     34,391,480        34,391,480        0.4414        15,096        15,180  
Series C
     14,468,290        14,468,290        2.0735        29,881        30,000  
Series D
     17,599,646        17,483,909        4.7523        82,976        83,089  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total convertible preferred stock
     113,419,184        112,987,810               $ 137,497      $ 137,876  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
The terms of Series Seed, Series A, Series B, Series C, and Series D preferred stock are as follows:
Voting
The holders of the Series Seed, Series A, Series B, Series C, and Series D preferred stock are entitled to vote, together with the holders of common stock, on all matters submitted to stockholders for a vote. Each preferred stockholder is entitled to the number of votes equal to the number of shares of common stock into which each preferred share is convertible at the time of such vote. Series A class is entitled to elect two representatives to the Board of Directors. Each of the Series B, Series C, and Series D classes is entitled to elect one representative to the Board of Directors. The Series Seed class is not entitled to elect a representative to the Board of Directors.
Dividends
The holders of the Series Seed, Series A, Series B, Series C, and Series D preferred stock are entitled to receive, when and as declared by the Board of Directors and out of funds legally available, dividends payable in preference and priority to any dividend payment on common stock. As of June 30, 2021, no dividends have been declared or paid by the Company.
Liquidation Preference
In the event of any liquidation, dissolution, change of control or winding-up of the affairs of the Company, the holders of the then outstanding Series Seed, Series A, Series B, Series C, and Series D preferred stock are entitled to receive, on a pari passu basis, an amount equal to the original issue price of $0.06, $0.29, $0.44, $2.07 and $4.75, respectively, per share plus any declared and unpaid dividends. If the amount paid would be greater had the preferred stockholders converted to common stock, the calculation of the amount to be distributed to the preferred shareholders shall be calculated as if the preferred stockholders had converted just prior to the distribution without having them first convert to common stock. After payment to the preferred stockholders, the remaining proceeds shall be distributed on a pro-rata basis
.
Conversion
Each share of Series Seed, Series A, Series B, Series C and Series D preferred stock, at the option of the holder, is convertible into a number of fully paid shares of common stock as determined by dividing the respective preferred stock issue price by the conversion price in effect at the time. The initial conversion price of Series Seed preferred stock is $0.06 per share and is subject to adjustment in accordance with anti- dilution provisions contained in the Company’s Certificate of Incorporation. The initial conversion price of Series A preferred stock is $0.29 per share and is subject to adjustment in accordance with anti-dilution provisions contained in the Company’s Certificate of Incorporation. The initial conversion price of Series B preferred stock is $0.44 per share and is subject to adjustment in accordance with anti-dilution provisions contained in the Company’s Certificate of Incorporation. The initial conversion price of Series C preferred stock is $2.07 per share and is subject to adjustment in accordance with anti-dilution provisions contained in the Company’s Certificate of Incorporation. The initial conversion price of Series D preferred stock is $4.75 per share and is subject to adjustment in accordance with anti-dilution provisions contained in the Company’s Certificate of Incorporation.
With respect to Series Seed, Series A, Series B, and Series C, conversion is at the holder’s option, however, all outstanding shares of preferred stock shall automatically convert immediately upon the closing of a sale of shares of common stock to the public at a price per share of at least $2.59 per share. At the election of the majority of all preferred stockholders and 10% of the outstanding Series C holders, shares of Series Seed, Series A, Series B, and Series C stock shall be automatically converted. With respect to
Series D, conversion is at the holder’s option, however, all outstanding shares of preferred stock shall automatically convert immediately upon the closing of a sale of shares of common stock to the public at a price per share of at least $4.75 per share. The Series D stock shall be automatically converted at the election of the majority of Series D holders.
Redemption
The preferred stock is not redeemable at the option of the holder.
Repurchases
There were no repurchases for the three and six months ended June 30, 2021. During the year ended December 31, 2020 the Company repurchased common stock from an employee. Concurrent to the repurchase,
the Company was contractually obligated to repurchase an additional 263,030 shares of common stock from this employee for $4.75 per share in 2021, subject to certain conditions. This obligation was waived by the parties in April of 2021.
Management determines the fair value of its common stock using the methodology described in the Summary of Significant Accounting Policies in its
S-4/A
proxy statement/prospectus, adjusting for changes in inputs based on material information known at the time of a repurchase transaction such as estimated timing to exit events and respective probabilities of such events occurring.
Common Stock Reserved for Future Issuance
The Company has reserved the following shares of common stock for future issuance:
 
    
June 30,
2021
    
December 31,
2020
 
Common stock options outstanding
     18,399,068        19,420,305  
Shares available for issuance under the plan
     3,322,966        4,649,322  
Convertible preferred stock outstanding
     113,083,557        112,987,810  
Warrants to purchase Series D convertible
preferred stock 
     19,990        115,737  
Common stock warrants outstanding
     —          190,000  
    
 
 
    
 
 
 
Total shares of authorized common stock reserved
for future issuance
     134,825,581        137,363,174  
    
 
 
    
 
 
 
Note 8. Convertible Preferred Stock, Common Stock and Stockholders’ Deficit
The following table summarizes details of convertible preferred stock authorized, issued and outstanding as of December 31, 2020 and 2019:
 
    
December 31, 2020
 
           
Share Issued
    
Issuance
    
Net
        
(in thousands, except for share counts)
  
Shares

Authorized
    
and
Outstanding
    
Price Per
Share
    
Carrying
Value
    
Liquidation
Preference
 
Series Seed
     18,233,848        17,918,211      $ 0.0618      $ 1,107      $ 1,107  
Series A
     28,725,920        28,725,920        0.2959        8,437        8,500  
Series B
     34,391,480        34,391,480        0.4414        15,096        15,180  
Series C
     14,468,290        14,468,290        2.0735        29,881        30,000  
Series D
     17,599,646        17,483,909        4.7523        82,976        83,089  
    
 
 
    
 
 
             
 
 
    
 
 
 
Total convertible preferred stock
     113,419,184        112,987,810               $ 137,497      $ 137,876  
    
 
 
    
 
 
             
 
 
    
 
 
 
    
December 31, 2019
 
           
Share Issued
    
Issuance
    
Net
        
(in thousands, except for share counts)
  
Shares
Authorized
    
and
Outstanding
    
Price Per
Share
    
Carrying
Value
    
Liquidation
Preference
 
Series Seed
     18,233,848        17,918,211      $ 0.0618      $ 1,107      $ 1,107  
Series A
     28,725,920        28,725,920        0.2959        8,437        8,500  
Series B
     34,391,480        34,391,480        0.4414        15,096        15,180  
Series C
     14,468,290        14,468,290        2.0735        29,881        30,000  
Series D
     17,599,646        17,336,616        4.7523        82,276        82,389  
    
 
 
    
 
 
             
 
 
    
 
 
 
Total convertible preferred stock
     113,419,184        112,840,517               $ 136,797      $ 137,176  
    
 
 
    
 
 
             
 
 
    
 
 
 
The terms of Series Seed, Series A, Series B, Series C, and Series D preferred stock are as follows:
Voting
The holders of the Series Seed, Series A, Series B, Series C, and Series D preferred stock are entitled to vote, together with the holders of common stock, on all matters submitted to stockholders for a vote. Each preferred stockholder is entitled to the number of votes equal to the number of shares of common stock into which each preferred share is convertible at the time of such vote. Series A class is entitled to elect two representatives to the Board of Directors. Each of the Series B, Series C, and Series D classes is entitled to elect one representative to the Board of Directors. The Series Seed class is not entitled to elect a representative to the Board of Directors.
Dividends
The holders of the Series Seed, Series A, Series B, Series C, and Series D preferred stock are entitled to receive, when and as declared by the Board of Directors and out of funds legally available, dividends payable in preference and priority to any dividend payment on common stock. As of December 31, 2020, no dividends have been declared or paid by the Company.
Liquidation Preference
In the event of any liquidation, dissolution, change of control or
winding-up
of the affairs of the Company, the holders of the then outstanding Series Seed, Series A, Series B, Series C, and Series D preferred stock are entitled
to receive, on a pari passu basis, an amount equal to the original issue price 
of $0.06, $0.29, $0.44, $2.07 and $4.75, respectively, per share plus any declared and unpaid dividends. If the amount paid would be greater had the preferred stockholders converted to common stock, the calculation of the amount to be distributed to the preferred shareholders shall be calculated as if the preferred stockholders had converted just prior to the distribution without having them first convert to common stock. After payment to the preferred stockholders, the remaining proceeds shall be distributed on a
pro-rata
basis.
Conversion
Each share of Series Seed, Series A, Series B, Series C and Series D preferred stock, at the option of the holder, is convertible into a number of fully paid shares of common stock as determined by dividing the respective preferred stock issue price by the conversion price in effect at the time. The initial conversion price of Series Seed preferred stock is $0.06 per share and is subject to adjustment in accordance with anti- dilution provisions contained in the Company’s Certificate of Incorporation. The initial conversion price of Series A preferred stock is $0.29 per share and is subject to adjustment in accordance with anti-dilution provisions contained in the Company’s Certificate of Incorporation. The initial conversion price of Series B preferred stock is $0.44 per share and is subject to adjustment in accordance with anti-dilution provisions contained in the Company’s Certificate of Incorporation. The initial conversion price of Series C preferred stock is $2.07 per share and is subject to adjustment in accordance with anti-dilution provisions contained in the Company’s Certificate of Incorporation. The initial conversion price of Series D preferred stock is $4.75 per share and is subject to adjustment in accordance with anti-dilution provisions contained in the Company’s Certificate of Incorporation
.
With respect to Series Seed, Series A, Series B, and Series C, conversion is at the holder’s option, however, all outstanding shares of preferred stock shall automatically convert immediately upon the closing of a sale of shares of common stock to the public at a price per share of at least $2.59 per share. At the election of the majority of all preferred stockholders and 10% of the outstanding Series C holders, shares of Series Seed, Series A, Series B, and Series C stock shall be automatically converted. With respect to Series D, conversion is at the holder’s option, however, all outstanding shares of preferred stock shall automatically convert immediately upon the closing of a sale of shares of common stock to the public at a price per share of at least $4.75 per share. The Series D stock shall be automatically converted at the election of the majority of Series D holders.
Redemption
The preferred stock is not redeemable at the option of the holder.
Repurchases
During the year ended December 31, 2020, the Company repurchased 263,031 shares of common stock from an employee for $4.75 per share net of withholding taxes of $0.2 million classified within accrued payroll for the employee’s related income tax liability. The fair value per share on the date of repurchase was $3.14. The repurchase resulted in additional compensation expense of $0.4 million for the value of the repurchase in excess of fair value. The expense is recognized in operating expenses within the general and administrative expenses on the consolidated statements of operations and comprehensive loss. The Company became contractually obligated to repurchase an additional 263,030 shares of common stock from this employee for $4.75 per share in 2021, with such obligation having been contingent but not probable of occurring as of December 31, 2020. However, the Company expects this obligation to be waived subsequent to the merger as described within Note 15 to the consolidated financial statements.
During the year ended December 31, 2019, the Company repurchased 244,691 shares of common stock from certain employees for $4.75 per share. The fair value per share on the date of repurchase was $2.55. The repurchase resulted in additional compensation expense of $0.5 million for the value of the repurchase in excess
 
of fair value. The expense is recognized in operating expenses in the research and development expenses on the consolidated statements of operations and comprehensive loss.
During the year ended December 31, 2019, the Company repurchased 315,637 shares of series Seed convertible preferred stock from an employee for $4.75 per share. The fair value per share on the date of repurchase was $2.55. The repurchase resulted in additional compensation expense of $0.7 million for the value of the repurchase in excess of fair value. The expense is recognized in operating expenses in the research and development expenses on the consolidated statements of operations and comprehensive loss.
Management determines the fair value of its common stock using the methodology described in Note 2 Summary of Significant Accounting Policies, adjusting for changes in inputs based on material information known at the time of a repurchase transaction such as estimated timing to exit events and respective probabilities of such events occurring.
Common Stock Reserved for Future Issuance
The Company has reserved the following shares of common stock for future issuance:
 
    
December 31,
 
    
2020
    
2019
 
Common stock options outstanding
     19,420,305        13,162,473  
Shares available for issuance under the plan
     4,649,322        2,823,610  
Convertible preferred stock outstanding
     112,987,810        112,840,517  
Warrants to purchase Series D convertible preferred stock
     115,737        263,030  
Common stock warrants outstanding
     190,000        190,000  
    
 
 
    
 
 
 
Total shares of authorized common stock reserved for future issuance
     137,363,174        129,279,630